Delayed Prostate Cancer Therapy Levittown NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Charles Carmine Conte
(516) 487-9454
600 Northern Blvd
Great Neck, NY
Steven Edward Vogl
(718) 519-7774
2220 Tiemann Ave
Bronx, NY
JENNA GOLDBERG, MD
(212) 932-4439
5141 Broadway
New York, NY
ROMAN PEREZ-SOLER, MD
(718) 920-4001
111 East 210Th Street
Bronx, NY
Louis Juden Reed, MD
718-863-8465
1180 Morris Park Ave
Bronx, NY
Arlyn Jill Apollo
(516) 256-3651
1000 N Village Ave
Rockville Centre, NY
Louis Juden Reed
(718) 863-8465
1180 Morris Park Ave
Bronx, NY
Farida P Chaudhri MD
(718) 358-3057
146-01 45th Ave
Flushing, NY
RICHARD LEE, MD
(516) 536-1455
242 Merrick Road
Rockville Centre, NY
Daniel Taft Friedman, MD
718-904-2555
111 E 210th St
Bronx, NY
Data Provided by:
      

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Hormone Therapy for Prostate Cancer Levittown NY
Hormone therapy to treat advanced prostate cancer can increase the risk of heart disease, but some types of hormone therapy appear to be safer than others, new research has found. The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.
- Hormone Therapy for Breast Cancer Levittown NY
- Hormone Therapy for Early Prostate Cancer Levittown NY
- Attack Of The Cancer Fighting Tomatoes Levittown NY
- Open Prostatectomy Versus Laparoscopic Procedure Levittown NY
- Drug Combo Proves Powerful Against Lung Cancer Levittown NY
- Exercise for Prostate Cancer Levittown NY
- Hormone Therapy for Lung Cancer Levittown NY
- Head and Neck Cancer Treatment Levittown NY
- Diagnosis of Prostate Cancer Levittown NY